FDA gives permission to Gentek Life Sciences to manufacture Amphotericin B injection in Wardha
Nagpur, May 15: With COVID-19 widespread another life-threatening disease that is seen taking a grip mostly among the recovered patients is Mucormycosis a serious but rare fungal infection.
Citing the rapid request of the life-saving injection needed in treating the patients Genetek Life Sciences facility in Wardha which is currently manufacturing another important medicine Remdesivir injections has received approval from Maharashtra FDA to manufacture Amphotericin B injection for Black Fungus infection (Mucormycosis), informed Office of Union Minister Nitin Gadkari through their tweet.
The production will start in Wardha in 15 days and the injection which usually cost to Rs 7,000 will be available just for Rs 1200.